找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Handbook for Venous Thromboembolism; Gregory Piazza,Benjamin Hohlfelder,Samuel Z. Goldh Book 2015 Springer International Publishing Switze

[复制链接]
查看: 48062|回复: 50
发表于 2025-3-21 16:54:31 | 显示全部楼层 |阅读模式
书目名称Handbook for Venous Thromboembolism
编辑Gregory Piazza,Benjamin Hohlfelder,Samuel Z. Goldh
视频video
概述The Handbook provides an algorithmic approach to the diagnosis, risk stratification and treatment of VTE.The Handbook provides a high-yield review of the clinical trials and evidence-based guidelines
图书封面Titlebook: Handbook for Venous Thromboembolism;  Gregory Piazza,Benjamin Hohlfelder,Samuel Z. Goldh Book 2015 Springer International Publishing Switze
描述This book has been developed over numerous iterations within the Brigham and Women’s Hospital to provide the most critical information for trainees and physicians, and thus it represents a truly practical guidebook for anyone who needs the key information on the diagnosis, management and prevention of venous thromboembolism. Specific areas of focus include understanding the risk factors for VTE and the role of the right ventricle in PE pathophysiology. Efficient algorithms for diagnosis and exclusion of DVT and PE are emphasized. An state-of-the-art review of current techniques for the management of high risk VTE, including submassive and massive PE, is presented. The novel oral anticoagulants are revolutionizing the way VTE is treated and are covered in detail.​
出版日期Book 2015
关键词Deep Vein Thrombosis; Pathophysiology; Pulmonary Embolism; Treatment; Venous Thromboembolism; pharmacothe
版次1
doihttps://doi.org/10.1007/978-3-319-20843-5
isbn_softcover978-3-319-20842-8
isbn_ebook978-3-319-20843-5
copyrightSpringer International Publishing Switzerland 2015
The information of publication is updating

书目名称Handbook for Venous Thromboembolism影响因子(影响力)




书目名称Handbook for Venous Thromboembolism影响因子(影响力)学科排名




书目名称Handbook for Venous Thromboembolism网络公开度




书目名称Handbook for Venous Thromboembolism网络公开度学科排名




书目名称Handbook for Venous Thromboembolism被引频次




书目名称Handbook for Venous Thromboembolism被引频次学科排名




书目名称Handbook for Venous Thromboembolism年度引用




书目名称Handbook for Venous Thromboembolism年度引用学科排名




书目名称Handbook for Venous Thromboembolism读者反馈




书目名称Handbook for Venous Thromboembolism读者反馈学科排名




单选投票, 共有 0 人参与投票
 

0票 0%

Perfect with Aesthetics

 

0票 0%

Better Implies Difficulty

 

0票 0%

Good and Satisfactory

 

0票 0%

Adverse Performance

 

0票 0%

Disdainful Garbage

您所在的用户组没有投票权限
发表于 2025-3-21 23:14:49 | 显示全部楼层
发表于 2025-3-22 01:57:50 | 显示全部楼层
,Pathophysiology of Deep Vein Thrombosis and Pulmonary Embolism: Beyond Virchow’s Triad,flammation, and hypercoagulability. The extent of the PE, the patient’s underlying cardiopulmonary reserve, and compensatory neurohumoral adaptations determine the overall hemodynamic impact. The right ventricle (RV) plays a central role in PE pathophysiology. A sudden increase in RV afterload due t
发表于 2025-3-22 05:38:25 | 显示全部楼层
Diagnosis of Deep Vein Thrombosis: Incorporating Clinical Suspicion with Laboratory Testing and Imatrategy that combines an assessment of clinical probability of the diagnosis with use of D-dimer testing and imaging when appropriate maximizes diagnostic accuracy. Venous ultrasound is the imaging test of choice for most patients with suspected DVT.
发表于 2025-3-22 08:42:57 | 显示全部楼层
发表于 2025-3-22 14:54:13 | 显示全部楼层
发表于 2025-3-22 21:00:48 | 显示全部楼层
Advanced Therapy for Venous Thromboembolism: Understanding the Role of Systemic Fibrinolysis, Catheary embolism (PE) syndromes. Advanced therapies for acute PE include systemic fibrinolysis, catheter-based “pharmacomechanical” intervention, and surgical pulmonary embolectomy. Choosing a particular advanced therapy depends on the individual patient’s risk for adverse outcomes due to VTE and for ma
发表于 2025-3-22 22:20:25 | 显示全部楼层
发表于 2025-3-23 03:27:18 | 显示全部楼层
Anticoagulation for Venous Thromboembolism: Selecting the Optimal Parenteral and Oral Anticoagulantunfractionated heparin, low-molecular-weight heparin, fondaparinux, argatroban, bivalirudin, warfarin, and the non-vitamin K oral anticoagulants (NOACs) rivaroxaban, dabigatran, apixaban, and edoxaban. The NOACs represent a major advance in anticoagulation for VTE with superior safety and equivalent
发表于 2025-3-23 08:52:25 | 显示全部楼层
Long-Term Management of Venous Thromboembolism: Strategies for Reducing the Risk of Recurrence,optimal duration and drug regimen requires an individualized assessment of the patient’s long-term risk of recurrence as well as bleeding. Warfarin and non-vitamin K oral anticoagulants (NOACs) have been validated for extended duration anticoagulation to prevent recurrent unprovoked VTE. Aspirin als
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-11 20:54
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表